Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

BLyS is involved in CLL biology and its low soluble serum levels related to a shorter time to first treatment (TFT). TACI is a BLyS receptor and can be shed from cells' surface and circulate in soluble form (sTACI). We investigated the impact of serum BLyS and sTACI levels at diagnosis in CLL p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kyrtsonis, Marie-Christine, Sarris, Katerina, Koulieris, Efstathios, Maltezas, Dimitrios, Nikolaou, Eftychia, Angelopoulou, Maria K., Bartzis, Vassiliki, Tzenou, Tatiana, Dimou, Maria, Siakandaris, Mariana P., Viniou, Nora A., Sachanas, Sotirios, Kalpadakis, Christina, Sfikakis, Petros P., Pangalis, Gerassimos A., Panayiotidis, Panayiotis
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4138780/
https://ncbi.nlm.nih.gov/pubmed/25162001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/159632
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados